| 일반논문 |
2025-03-03 |
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes |
| 일반논문 |
2025-03-03 |
Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19 |
| 일반논문 |
2024-04-25 |
PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug-drug interactions with clarithromycin and paroxetine |
| 일반논문 |
2024-02-01 |
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism |
| 일반논문 |
2024-01-01 |
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes |
| 일반논문 |
2023-12-08 |
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict the Pharmacokinetics of Irbesartan in Different <i>CYP2C9</i> Genotypes |
| 일반논문 |
2023-09-30 |
블렌디드 러닝을 활용한 팀 기반 학습 실습 수업에서 약학대학 학생의 학습만족도와 플랫폼 선호도: 예비 연구 |
| 일반논문 |
2023-08-01 |
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone |
| 일반논문 |
2023-04-25 |
Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the PK and PD of gliclazide in healthy subjects |
| 일반논문 |
2023-03-01 |
Systematic Search and Qualitative Evaluation of Dietary Supplement Mobile Applications: Using the Mobile Application Rating Scale (MARS) |
| 일반논문 |
2023-02-01 |
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects |
| 일반논문 |
2023-01-01 |
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone |
| 일반논문 |
2022-08-01 |
Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes |
| 일반논문 |
2022-06-01 |
Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes |
| 일반논문 |
2022-05-01 |
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism |
| 일반논문 |
2022-02-01 |
Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects |
| 일반논문 |
2021-12-01 |
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes |
| 일반논문 |
2021-11-01 |
Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin to related CYP2D6*10 allele |
| 일반논문 |
2021-11-01 |
Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients |
| 일반논문 |
2021-08-01 |
Korean Women’s Knowledge Level and Social Perception toward Oral Contraceptives and Perspectives on Pharmacy Visits |
| 일반논문 |
2021-07-01 |
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism |
| 일반논문 |
2020-11-29 |
ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan |
| 일반논문 |
2020-11-01 |
Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes |
| 일반논문 |
2020-11-01 |
Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide |
| 일반논문 |
2020-08-01 |
Evaluation of Patient Assessment and Counseling of Over-the-counter Oral Contraceptives by Community Pharmacists in South Korea: A Mystery Shopper Study |
| 일반논문 |
2019-12-01 |
Effects of steady-state clarithromycin on the pharmacokinetics of zolpidem in healthy subjects |
| 일반논문 |
2019-10-01 |
Effect of icatibant on angiotensin‐converting enzyme inhibitor‐induced angioedema: A meta‐analysis of randomized controlled trials |
| 일반논문 |
2019-01-01 |
Evaluation of medication use and pharmacy services for visually impaired persons: Perspectives from both visually impaired and community pharmacists |
| 일반논문 |
2018-05-01 |
Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes |
| 일반논문 |
2018-03-01 |
Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites
|
| 일반논문 |
2018-01-01 |
Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review |
| 일반논문 |
2017-12-01 |
Inhibition of salivary secretion by tolterodine transdermal patch |
| 일반논문 |
2017-11-01 |
Simultaneous determination of tolterodine and its two metabolites, 5-hydroxymethyltolterodine and N-dealkyltolterodine in human plasma using LC-MS/MS and its application to a pharmacokinetic study |
| 일반논문 |
2017-07-01 |
Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects |
| 일반논문 |
2017-03-01 |
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite |
| 일반논문 |
2016-08-01 |
Characteristics and Career Plans of Korean International Students and Graduates of Doctor of Pharmacy Program in the United States |
| 일반논문 |
2016-06-01 |
약학대학 학생들의 교과외활동 현황 평가 및 동기에 대한 분석 |
| 일반논문 |
2016-06-01 |
근 · 현대사 이후 한국인의 최다 선호 일반의약품의 추이에 대한연대별 분석 및 종합적 의의에 대한 평가 |
| 일반논문 |
2015-11-01 |
Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites. |
| 일반논문 |
2015-06-01 |
Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects |
| 일반논문 |
2015-04-01 |
Determination of zolpidem in human plasma by liquid chromatography-tandem mass spectrometry for clinical application. |
| 일반논문 |
2014-12-01 |
국내 임상약학 교과과정 현황 및 미국 교과과정과의 비교 |
| 일반논문 |
2014-11-01 |
Simultaneous determination of flurbiprofen and its hydroxy metabolite in human plasma by liquid chromatography-tandem mass spectrometry for clinical application |
| 일반논문 |
2014-11-01 |
Ursodeoxycholic acid, an inhibitor of hepatocyte nuclear factor 1alpha, did not increase the systemic exposure of pitavastatin. |
| 일반논문 |
2014-10-01 |
Use of novel oral anticoagulants for the treatment of venous thromboembolism and its considerations in Asian patients |
| 일반논문 |
2014-08-31 |
한국 병원의 항생제 치료를 위한 항생제피부반응시험에 대한유효성 및 위험성 평가 |
| 일반논문 |
2014-08-01 |
Response to Suarez-Kurtz's comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals. |
| 일반논문 |
2014-04-30 |
한국적 의학 기준에 근거한 고혈압환자의 Angiotensin II Receptor Blockers와 Calcium Channel Blockers의 약물 평가 |
| 일반논문 |
2014-02-01 |
Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals |
| 일반논문 |
2014-02-01 |
Effects of CYP2C19 Genetic Polymorphisms on Atomoxetine Pharmacokinetics |
| 일반논문 |
2013-07-01 |
Effects of OCT2 c.602C > T genetic variant on the pharmacokinetics of lamivudine |
| 일반논문 |
2012-12-01 |
Determination of tolperisone in human plasma by liquid chromatography/tandem mass spectrometry for clinical application |
| 일반논문 |
2012-09-01 |
Effects of CYP2C9(star)1/(star)3 and (star)1/(star)13 on the pharmacokinetics of losartan and its active metabolite E-3174 |
| 일반논문 |
2012-09-01 |
Effects of CYP2C9*1/*3 and *1/*13 on the pharmacokinetics of losartan and its active metabolite E-3174. |
| 일반논문 |
2012-06-01 |
Evaluating drug therapy decision making in patients with epilepsy |
| 일반논문 |
2012-06-01 |
Evaluating drug therapy decision making in patients with epilepsy. |
| 일반논문 |
2012-05-01 |
Effects of the SLCO1B1*15 allele on the pharmacokinetics of pitavastatin |
| 일반논문 |
2012-05-01 |
Effects of the SLCO1B1*15 allele on the pharmacokinetics of pitavastatin. |
| 일반논문 |
2011-10-01 |
Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics. |
| 일반논문 |
2011-10-01 |
Characteristics of 5-hydroxytryptamine receptors involved in contraction of feline ileal longitudinal smooth muscle. |
